Some of these genes were previously shown to be prognostic biomarkers in different tumors, for example, high CANT1 expression was related to a poor prognosis in prostate and lung carcinomas,26, 28 and PLS3 may be useful as a biomarker for identifying recurrences or a poor prognosis in some cancers.29, 30. This evidence concerns the gene PLS3 and cancer.